Subscribe
Contact Us
About Us
Advertise
Home
News
News from MM&M
Off the Wire
Newsletters
PMD Profiles
Agency Creative Showcase
Publication Connection
PMD Marketplace
Careers
About Us
Additional Resources
MM&M
MM&M Jobs
MAHF
Voi Consulting
Advertise
Subscribe
Get Listed
Additional Resources
RSS
|
Login
|
Register
Merger
Sanofi-aventis and Merck Appoint Raul Kohan as CEO for the New Animal Health Joint Venture
July 27, 2010
Proposed JV to be called Merial-Intervet
Celgene to Acquire Abraxis BioScience Inc.
June 30, 2010
Celgene to pay $2.9 billion in cash and stock
Valeant and Biovail Agree to Merge
June 21, 2010
Combination Creates Leader in Specialty Pharmaceuticals
Astellas buys OSI Pharma for $4 billion
May 17, 2010
Deal will enable the early establishment of cancer business base
Javelin Pharmaceuticals Delivers Notice of Intent to Terminate Merger Agreement with Myriad Pharmaceuticals
April 12, 2010
Javelin Receives Binding Acquisition Commitment from Hospira
Horizon Therapeutics and Nitec Pharma Complete Merger and Combine Businesses
April 01, 2010
Combined company has one approved product and two late-stage candidates
Facet Biotech Stockholders Reject Biogen Idec Tender Offer
December 17, 2009
The company will continue to pursue other opportunities
Silence Therapeutics to Merge with Intradigm Corp
December 16, 2009
Merger to Create Leading RNAi Therapeutics Company
Biogen Idec Stands Ready to Close Its $17.50 Per Share All-Cash Tender Offer for Facet Biotech
December 14, 2009
Biogen Idec Reminds Stockholders to Tender Their Shares by December 16, 2009
Pfizer And Wyeth Become One: Working Together For A Healthier World
October 16, 2009
Establishes and Expands Leadership in Human, Animal and Consumer Health
BioSante Pharmaceuticals and Cell Genesys Announce Final Exchange Ratio for Merger
September 22, 2009
Exchange Ratio Fixed at 0.1828
Biogen Idec Commences Tender Offer for Facet Biotech
September 21, 2009
Offers to Acquire All Outstanding Shares of Facet for $14.50 Per Share in Cash
Noven and Hisamitsu Enter into Definitive Merger Agreement
July 14, 2009
Hisamitsu to Commence All-Cash Tender Offer for 100% of Noven Shares
CombinatoRx and Neuromed Sign Merger Agreement
July 01, 2009
Merger to Create a Sustainable Biotechnology Company
Latest News
Sinobiomed Announces New Chief Executive Officer
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Biodel Announces Name Change for Lead Product Candidate
Pfizer to Acquire FoldRx Pharmaceuticals
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
pSivida Announces Iluvien® Receives FDA Priority Review for Treatment of Diabetic Macular Edema
Medicis Announces Approval of Additional Strengths of Solodyn(R)
Meda acquires Alaven, a US specialty pharma company
Luminex Announces Commercial Launch of New Cystic Fibrosis Test
Most Popular
Most Emailed
Most Recent
Luminex Announces Commercial Launch of New Cystic Fibrosis Test
Novartis receives FDA approval of Tekamlo
Meda acquires Alaven, a US specialty pharma company
XenoPort Announces Changes to Executive Team
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
Pfizer to Acquire FoldRx Pharmaceuticals
Medicis Announces Approval of Additional Strengths of Solodyn(R)
pSivida Announces Iluvien® Receives FDA Priority Review for Treatment of Diabetic Macular Edema
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Meda acquires Alaven, a US specialty pharma company
Novo Nordisk Creates 'App' to Help Doctors Dose Insulin, Supporting New Trend in Diabetes Care
Biodel Announces Name Change for Lead Product Candidate
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
Medicis Announces Approval of Additional Strengths of Solodyn(R)
FDA Accepts Sanofi Pasteur's Application to Expand Indication of Menactra® Vaccine to Infants and Toddlers
Sinobiomed Announces New Chief Executive Officer
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
Pfizer to Acquire FoldRx Pharmaceuticals
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Sinobiomed Announces New Chief Executive Officer
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Biodel Announces Name Change for Lead Product Candidate
Pfizer to Acquire FoldRx Pharmaceuticals
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
pSivida Announces Iluvien® Receives FDA Priority Review for Treatment of Diabetic Macular Edema
Medicis Announces Approval of Additional Strengths of Solodyn(R)
Meda acquires Alaven, a US specialty pharma company
Luminex Announces Commercial Launch of New Cystic Fibrosis Test
Popular Topics
Acquisition
Agency
Animal Health
Biopharmaceutical
Biotech
Business
Clinical Management
Collaboration
Diagnostic
Marketing & Communications
Medical Device
Medical Equipment
Merger
New Hire
New Hires
Personnel
Pharmaceutical
Pharmaceutical Products
Pipeline
Product Acquisition
Product Launch
Product Promotion
Regulatory
Regulatory Approval
Research & Development